TY  - GEN
AU  - Denys,Hannelore
AU  - Martinez-Mena,Corina L
AU  - Martens,Marc T
AU  - D'Hondt,Randal G
AU  - Graas,Marie-Pascale L
AU  - Evron,Ella
AU  - Fried,Georgeta
AU  - Ben-Baruch,Noa E
AU  - Vulsteke,Christof
AU  - Van Steenberghe,Mona M
TI  - Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
SN  - 1573-7217
PY  - 2021///0108
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Immunological
KW  - administration & dosage
KW  - Belgium
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Carcinoma, Ductal, Breast
KW  - Carcinoma, Lobular
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Israel
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Prognosis
KW  - Prospective Studies
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Trastuzumab
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s10549-020-05604-7
ER  -